标题
Current status of therapeutic monoclonal antibodies against SARS-CoV-2
作者
关键词
SARS CoV 2, COVID 19, Antibodies, Antibody therapy, Monoclonal antibodies, Viral vaccines, Microbial mutation, SARS
出版物
PLoS Pathogens
Volume 17, Issue 9, Pages e1009885
出版商
Public Library of Science (PLoS)
发表日期
2021-09-04
DOI
10.1371/journal.ppat.1009885
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies
- (2021) Maxwell T. Finkelstein et al. Viruses-Basel
- A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
- (2021) Cheolmin Kim et al. Nature Communications
- Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
- (2021) Yunjiao Zhou et al. Cell Reports
- Process and Operations Strategies to Enable Global Access to Antibody Therapies
- (2021) Brian Kelley et al. BIOTECHNOLOGY PROGRESS
- Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
- (2021) Emma S. Winkler et al. CELL
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
- (2021) Hejun Liu et al. Cell Host & Microbe
- Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
- (2021) Raoul De Gasparo et al. NATURE
- Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
- (2021) Ge Song et al. Nature Communications
- A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
- (2021) Chunyan Wang et al. Nature Communications
- Tackling COVID-19 with neutralizing monoclonal antibodies
- (2021) Davide Corti et al. CELL
- SARS-CoV-2 variants of concern are emerging in India
- (2021) Jasdeep Singh et al. NATURE MEDICINE
- SARS-CoV-2 variants, spike mutations and immune escape
- (2021) William T. Harvey et al. NATURE REVIEWS MICROBIOLOGY
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Developing therapeutic monoclonal antibodies at pandemic pace
- (2020) Brian Kelley NATURE BIOTECHNOLOGY
- A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
- (2020) Wafaa B. Alsoussi et al. JOURNAL OF IMMUNOLOGY
- CoV-AbDab: the Coronavirus Antibody Database
- (2020) Matthew I J Raybould et al. BIOINFORMATICS
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
- (2020) Christopher O. Barnes et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More